Dog-rose, Cranberry Leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in Diabetes Mellitus
Type 2 Diabetes
About this trial
This is an interventional treatment trial for Type 2 Diabetes focused on measuring Type 2 diabetes, Insulin resistance, Lipochromin, Vaccinium macrocarpon, Medicago sativa, Trigonella, Fenugreek, Lemon Beebrush, Urtica dioica, Rhus, Sumac
Eligibility Criteria
Inclusion Criteria: At least one year of diagnosis of type 2 diabetes according to the criteria of the World Health Organization, Hemoglobin A1c (HbA1c) > 7.0% or fasting blood glucose > 7.0 mmol/L, Body mass index (BMI) more than 23 kg/m2 and less than 35. Exclusion Criteria: Comorbidities, including type 1 diabetes, cardiovascular disease, thyroid disease, liver disease, kidney disease, cancer, mental disorders, and the use of drugs related to the aforementioned diseases, Pregnancy, Patients with a BMI over 35 who were on a weight loss diet or had taken weight loss supplements for less than 6 months A history of allergy to one of the components of the nestling fruit, carob leaf, carob fruit, alfalfa seed, fenugreek seed, lemon, Nettles and sumac and also Lactating women Regularly consuming cigarettes or alcohol Using psychiatric drugs or insulin Changing in the medication regimen during the trial period. For example, to start receiving insulin therapy, become pregnant, or no longer follow medication and dietary instructions.
Sites / Locations
- Imam Reza hospital and clinic of Salamat
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Capsules containing the combination products
Placebo
Capsules containing dog-rose, Cranberry leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica, and Sumac
Placebo capsules containing maltodextrin